Compare Repligen Corporation Common Stock (RGEN) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Unity Software Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Unity Software Inc trades at $40.8 (market cap $20.52B). The key difference: Unity Software Inc is the larger of the two by market cap, and Unity Software Inc is more actively traded (4,656,122 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Unity Software Inc for 50 Days on average.
| RGEN | U | |
|---|---|---|
Market Cap | $11.14B | $20.52B |
Volume | 1,259,263 | 4,656,122 |
Sector | Health | Technology |
52-Week High | $194.57 | $49.47 |
52-Week Low | $102.87 | $17.13 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $11.02B | $20.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Unity Software (U) trades at $46.63, down 0.11% on the day, with strong analyst support (83% buy ratings) and a $48.01 consensus price target. The stock shows bullish technical momentum despite negative profitability metrics, with revenue stabilizing around $1.8B and improving net margins from -66% in 2022 to -22% in 2025. Recent positive sentiment stems from Meta VR partnership news and institutional accumulation.
Unity presents a growth story with improving operational metrics but faces profitability challenges. The stock offers 3% upside to consensus targets with strong institutional backing, though persistent losses and high valuation multiples require careful risk assessment amid competitive pressures in the gaming engine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
